{"filing": {"accession": "0001493152-25-001051", "cik": "0000318306", "ticker": "ABEO", "company_name": "ABEONA THERAPEUTICS INC.", "form_type": "S-8", "filing_type": "S-8", "filing_date": "2025-01-06", "accepted_datetime": null, "acceptance_datetime": null, "accepted_at": null, "primary_doc_url": "forms-8.htm", "filing_url": null, "period_of_report": null}, "html_url": "/api/filings/000149315225001051/stream", "exhibits": [{"exhibit_number": "5.1", "exhibit_type": "5", "description": "Opinion of Willkie Farr & Gallagher LLP", "filename": "ex5-1.htm", "edgar_url": "https://www.sec.gov/Archives/edgar/data/318306/000149315225001051/ex5-1.htm", "category": "other", "incorporated_by_reference": false}, {"exhibit_number": "10.7", "exhibit_type": "10", "description": "", "filename": "ex107.htm", "edgar_url": "https://www.sec.gov/Archives/edgar/data/318306/000149315225001051/ex107.htm", "category": "contracts", "incorporated_by_reference": false}, {"exhibit_number": "23.1", "exhibit_type": "23", "description": "Consent of Whitley Penn LLP", "filename": "ex23-1.htm", "edgar_url": "https://www.sec.gov/Archives/edgar/data/318306/000149315225001051/ex23-1.htm", "category": "other", "incorporated_by_reference": false}, {"exhibit_number": "23.2", "exhibit_type": "23", "description": "Consent of Deloitte & Touche LLP", "filename": "ex23-2.htm", "edgar_url": "https://www.sec.gov/Archives/edgar/data/318306/000149315225001051/ex23-2.htm", "category": "other", "incorporated_by_reference": false}, {"exhibit_number": "23.3", "exhibit_type": "23", "description": "Consent of Willkie Farr & Gallagher LLP (included in Exhibit 5.1 hereto)", "filename": "", "edgar_url": "https://www.sec.gov/Archives/edgar/data/318306/000149315225001051/ex5-1.htm", "category": "other", "incorporated_by_reference": false}, {"exhibit_number": "107", "exhibit_type": "107", "description": "Filing Fee Table", "filename": "", "edgar_url": "https://www.sec.gov/Archives/edgar/data/318306/000149315225001051/ex107.htm", "category": "other", "incorporated_by_reference": false}, {"exhibit_number": "4.1", "exhibit_type": "4", "description": "Restated Certificate of Incorporation of Abeona Therapeutics Inc.", "filename": "", "edgar_url": "https://www.sec.gov/Archives/edgar/data/318306/000114420419025271/tv520699_ex3-1.htm", "category": "incorporation", "incorporated_by_reference": true}, {"exhibit_number": "4.2", "exhibit_type": "4", "description": "Certificate of Amendment to Restated Certificate of Incorporation of Abeona Therapeutics Inc.", "filename": "", "edgar_url": "https://www.sec.gov/Archives/edgar/data/318306/000149315222018257/ex3-1.htm", "category": "incorporation", "incorporated_by_reference": true}, {"exhibit_number": "4.3", "exhibit_type": "4", "description": "Second Amended and Restated Bylaws of Abeona Therapeutics Inc.", "filename": "", "edgar_url": "https://www.sec.gov/Archives/edgar/data/318306/000149315224026640/ex3-1.htm", "category": "incorporation", "incorporated_by_reference": true}, {"exhibit_number": "99.1", "exhibit_type": "99", "description": "Second Amended and Restated Abeona Therapeutics Inc. 2023 Equity Incentive Plan", "filename": "", "edgar_url": "https://www.sec.gov/Archives/edgar/data/318306/000149315224044862/formdef14a.htm", "category": "contracts", "incorporated_by_reference": true}], "sections": [], "tables": [], "exhibits_pending": false, "cdn_html": false, "response_time_ms": 60}